Liver retransplant for primary disease recurrence.

Area of Science:

• Hepatology
• Transplant Surgery
• Medical Ethics

Background:

• Liver retransplant is the sole option for irreversible graft failure.
• Organ scarcity raises ethical concerns regarding equitable resource distribution.
• Retransplantation incurs higher costs and lower survival rates than primary transplants.

Purpose of the Study:

• To review predictive factors influencing liver retransplant outcomes.
• To focus on outcomes in patients with recurrent liver diseases.
• To inform selection criteria for liver retransplant in the Model of End-stage Liver Disease (MELD) era.

Main Methods:

• Literature review of studies on liver retransplantation outcomes.
• Analysis of prognostic factors affecting patient and graft survival.
• Examination of indications for early and late liver retransplant.

Main Results:

• Primary nonfunction and hepatic artery thrombosis are key early retransplant indications.
• Late indications include chronic rejection, biliary issues, and disease recurrence (e.g., hepatitis C).
• Recipient prognostic factors are crucial for retransplant decisions due to unavailable donor data.

Conclusions:

• Liver retransplant decisions require stringent selection criteria, particularly for late indications.
• Understanding predictive factors is vital for optimizing outcomes in liver retransplant recipients.
• Further research is needed to refine selection and improve survival in retransplanted patients.